BIOLASE, Inc. (NASDAQ:BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.01 per share, are exercisable immediately, and will not expire until exercised. The offering is expected to close on January 12, 2023, subject to customary closing conditions.
GoPro Undergoes Restructuring: Aims To Slash Costs With Workforce And Office Space Cuts
GoPro to reduce global workforce by 4% to cut costs and improve leverage. Estimated $7.5M in costs and $2.2M in office charges through Jan 2027.
